Power3 Medical Products, Inc. (OTC:PWRM)
PWRM recently delivered four poster presentations at the 2010 ICAD. These presentations discussed PWRM’s diagnostic test, NuroPro, and focused on PWRM’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.
“In preparation for commercialization, our objective at this meeting was to show how Power3’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease,” stated Dr. Ira L. Goldknopf, PWRM ’s President & Chief Scientific Officer. “It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.”
To learn more about PWRM visit: http://www.Power3Medical.com
Tecumseh Products Company (Nasdaq:TECUB) a leading global manufacturer of compressors and related products, reported on November 4, 2010 for the quarter and nine months ended September 30, 2010, a net loss of $3.2 million, or $0.17 per diluted share and a net loss of $50.2 million, or $2.72 per diluted share, respectively. This compares with a net loss of $14.1 million, or $0.76 per diluted share, and a net loss of $62.9 million, or $3.40 per diluted share, for the same periods in 2009.
For the quarter and nine months ended September 2010 adjusted operating loss(1) totaled $2.8 million, and $1.2 million, respectively, compared to an adjusted operating loss(1) of $10.6 million and $62.8 million for the same periods in 2009. The quarter and nine months ended September 30, 2010 operating loss, as reported under GAAP, was $3.7 million and $50.6 million compared with a net loss of $14.2 million and $73.4 million for the same period in 2009.
BankFinancial Corp. (Nasdaq:BFIN) announced that it filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 and a Quarterly Financial and Statistical Supplement on Form 8-K with the U.S. Securities and Exchange Commission on November 1, 2010.
BankFinancial reported net income of $737,000, or $0.04 per common share, for the three months ended September 30, 2010 compared to $1.4 million, or $0.07 per common share, for the three months ended September 30, 2009. Net income for the nine months ended September 30, 2010 was $1.2 million, or $0.06 per common share, compared to $858,000, or $0.04 per common share for the nine months ended September 30, 2009.
BankFinancial Corporation is the holding company for BankFinancial, F.S.B., a full-service, community-oriented bank providing financial services to individuals, families and businesses through 18 full-service banking offices, located in Cook, DuPage, Lake and Will Counties, Illinois. BankFinancial Corporation's common stock trades on the Nasdaq Global Select Market under the symbol BFIN.
Dover Saddlery, Inc. (Nasdaq:DOVR) will release its third quarter 2010 results before the market opens on Tuesday, November 9, 2010. Dover Saddlery executives will host a conference call to review results at 8:30 am ET on the same day. Interested parties are invited to listen to the call live via webcast.
Dover Saddlery, Inc. (NASDAQ:DOVR) is the leading multichannel retailer of equestrian products in the United States. Founded in 1975 in Wellesley, Massachusetts, by United States Equestrian team members, Dover Saddlery has grown to become The SourceÂ® for equestrian products. Dover offers a broad and distinctive selection of competitively priced, brand-name products for horse and rider through catalogs, the Internet and company-owned retail stores. Dover Saddlery, Inc. serves the English rider and through Smith Brothers, the Western rider.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).